Disappointing these issues were not addressed during the Q&A on the 23/3 after many questions were submitted prior to the zoom call. IMO this will be below 8 cents very soon with the 6-8 million revenue guidance only in shareholders dreams at night. FDA was supposed to be the pinnacle moment for Respiri, however the firework failed but still provided a rich exit point for the smart ones. good luck to all
Marjan Mikel informed attendees at the NWR virtual conference that he will have FDA approval before the end of this quarter as promised.The very concerning issue is the FDA decision was made 11/03/21 8 days prior and volume increased dramatically. Why a trading halt on the 19th after the presentation ????
510(k) Premarket Notification (fda.gov)
UnderListingRule 3.1, an entity mustdiscloseall information concerning it that it becomes aware of from any source and of any character, if a reasonable person would expect the information to have a material effect on the price or value of its securities.
https://youtu.be/-sc8um4H584
Device Classification NameAbnormal Breath Sound Device510(K) NumberK202062Device NameWheezo WheezeRate DectorApplicantApplicant ContactSamaneh SarrafCorrespondent
Respiri Limited Level 10, 446 Collins Street Melbourne, AU 3000 Correspondent ContactSamaneh SarrafRegulation Number868.1900Classification Product Code
Respiri Limited Level 10, 446 Collins Street Melbourne, AU 3000 Date Received07/27/2020Decision Date03/11/2021DecisionSubstantially Equivalent (SESE)Regulation Medical SpecialtyAnesthesiology510k Review PanelAnesthesiologyTypeTraditionalReviewed By Third PartyNoCombination ProductNo
PHZ No data available in table
- Forums
- ASX - By Stock
- questions remain unanswered
Disappointing these issues were not addressed during the Q&A on...
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RSH (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.29M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 140913 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 140913 | 0.056 |
1 | 200000 | 0.055 |
3 | 688592 | 0.053 |
1 | 12000 | 0.047 |
1 | 311458 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 30000 | 1 |
0.055 | 119047 | 1 |
0.060 | 100000 | 1 |
0.064 | 150000 | 2 |
0.065 | 350000 | 2 |
Last trade - 16.12pm 14/10/2024 (20 minute delay) ? |
Featured News
RSH (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online